FTXHvsSLTYETF Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) belongs to the US Health Care segment. YieldMax Ultra Short Option Income Strategy ETF (SLTY) is part of the Alternatives segment. FTXH's top 3 sector exposures are and Health Care. In contrast, SLTY's top sector exposures are and Consumer Discretionary.Communication Services, Industrials, FTXH is less expensive with a Total Expense Ratio (TER) of 0.6%, versus 1.24% for SLTY. FTXH is up 1.76% year-to-date (YTD) with +$9M in YTD flows. SLTY performs worse with -4.29% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of FTXH and SLTY below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FTXH vs SLTY performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH SLTY | +1.29%-6.31% | -1.76%+4.78% | +1.76%-4.29% | +33.23%n/a | +32.78%n/a | +37.48%n/a |
| Flows | FTXH SLTY | +$2M+$3M | +$7M+$6M | +$9M+$3M | +$11M- | -$7M- | +$3M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH SLTY | +17.57%+13.82% | +18.14%n/a | +16.08%n/a | +15.79%n/a |
| Max drawdown | FTXH SLTY | -7.50%-8.17% | -7.50%n/a | -19.32%n/a | -19.32%n/a |
| Max drawdown duration | FTXH SLTY | 57d29d | 57dn/a | 393dn/a | 393dn/a |
FTXH | SLTY | |
Last sale 4/29/2026 at 1:30 PM | $33.31 | $26.18 |
| Previous close 04/28/2026 | $33.50 | $26.63 |
| Consolidated volume 04/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FTXH | SLTY | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FTXH | SLTY | |
|---|---|---|
| Last price | $33.31 | $26.18 |
| 1D performance | -0.59% | -1.66% |
| AuM | $30.11 M | $19.96 M |
| E/R | 0.6% | 1.24% |
FTXH | SLTY | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | First Trust | YieldMax ETFs |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | - |
| N° of holdings | 50 | 24 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | August 21, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
